SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-023347
Filing Date
2023-07-03
Accepted
2023-07-03 17:46:13
Documents
1
Period of Report
2023-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3965
  Complete submission text file 0001493152-23-023347.txt   5405
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1300 N. KELLOGG DRIVE, SUITE D ANAHEIM CA 92807
Business Address
Mulroy Michael H. (Reporting) CIK: 0001509725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 231066103